Stay Informed

Sign up for news & alerts

Already signed up?
Login here

take action
For every $1 states spend dollar sign on substance misuse and addiction, 94 cents go to shovel up the consequences instead of for treatment and prevention. TELL YOUR LEGISLATORS

What Can I Do?



Continuing Education
Free online courses for addiction counselors LEARN ONLINE

Get Help
Need alcohol or drug help for yourself or someone else? GET HELP

 

Purdue Wins Case Involving OxyContin Sales
February 14, 2005

Share Share Email
Email
Print
Print
SubscribeSubscribe
News Summary

A former OxyContin saleswoman has lost a case against pharmaceutical firm Purdue Pharma in which she alleged that the company pressured her to illegally market the drug to doctors, the Tampa Tribune reported Feb. 9.

Karen White of Lakeland, Fla., had charged that Purdue Pharma fired her from her sales job because she would not pressure doctors to prescribe high doses of OxyContin to fight pain. Purdue countered that their sales tactics were legal and that White was fired because she did not sell enough.

White had sought $138,000 in back wages plus $690,000 for emotional pain.

"Today's verdict vindicates Purdue Pharma," the company said in a statement following the jury decision. "The false claims made against us now have been formally rejected by a court of law ... We remain committed to serving physicians and the patients in their care by providing innovative prescription and nonprescription products and promoting them in an ethical way."

White, who said that an appeal is possible, expressed disappointment. Her attorney, Robert McKee, said in his closing statement, "Purdue would have you believe it was on a mission to relieve people of their pain ... Purdue, with its aggressive marketing program, was on a mission to relieve people of their money. This marketing system was corrupt. It was corrupted by money, corrupted by greed, and this lady refused to go along."

But Purdue attorney Gordon Smith said White lost her job because of her "personal disagreement with promoting the drug in an entirely legal way." He said those tactics included educating doctors about OxyContin's utility at higher doses and helping physicians overcome their concerns about writing high-dose prescriptions.

COMMENTS ON THIS ARTICLE:
(Comments now appear first to last)

Your Turn! Post a public comment (guidelines):

Name:

Comment:
(limit 250
words)

Enter this word
(help):
Change

GUIDELINES: 
To keep this feature useful for everyone, please:

  1. Keep it clean, courteous, brief, and on-topic. Comments are for discussion of the above article, not general rants or manifestos. Serial comments intended to circumvent the 250-word limit may be deleted.

  2. Do not post promotional web links, personal information or requests for assistance (get help).

  3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercial posts are prohibited. We reserve the right to remove comments. (Report a comment).

Have questions or feedback? Contact us.